연구성과로 돌아가기
2024 연구자 정보 (45 / 1079)
※ 컨트롤 + 클릭으로 열별 다중 정렬 가능합니다.
Excel 다운로드
| Author Name | 제1저자 여부 | 교신저자 여부 | Address | ResearcherID | ORCID | Paper Title | WoS Edition | 최상위 JCR(%) | WoS Category | Related Email |
|---|---|---|---|---|---|---|---|---|---|---|
|
Heo, Mi Hwa (Heo, MH) |
Keimyung Univ Dongsan Hosp, Dept Internal Med, Div Hemato Oncol, Daegu, South Korea |
|
|
[JCR상위 1.7] Neoadjuvant Docetaxel, Oxaliplatin, and S-1 Plus Surgery and Adjuvant S-1 for Resectable Advanced Gastric Cancer: Updated Overall Survival Outcomes From Phase III PRODIGY | SCIE | 1.7 | ONCOLOGY | ykkang@amc.seoul.kr; | ||
|
Heo, Yujin (Heo, Y) |
|
|
[JCR상위 1.7] Analysis of prognostic factors in uterine cervical malignancy treated with concurrent chemoradiation therapy: A retrospective study in two centers in Korea. | SCIE | 1.7 | ONCOLOGY | ||||
|
Hiremath, Amogh (Hiremath, A) |
AAO-3178-2021 Hiremath, Amogh |
|
[JCR상위 1.7] An interpretable AI-derived radiology signature to identify patients at risk of progression on the PACIFIC regimen for unresectable non-small cell lung cancer [JCR상위 1.7] CheckpointPx: A predictive radiology AI model of immune checkpoint inhibitor (ICI) benefit in non-small cell lung cancer (NSCLC) [JCR상위 1.7] AI-based radiomics model for predicting immune checkpoint inhibitor-related pneumonitis (CIP) in patients with advanced NSCLC: An external validation study |
SCIE | 1.7 | ONCOLOGY | ||||
|
Hong, Ilene (Hong, I) |
|
|
[JCR상위 1.7] An interpretable AI-derived radiology signature to identify patients at risk of progression on the PACIFIC regimen for unresectable non-small cell lung cancer [JCR상위 1.7] CheckpointPx: A predictive radiology AI model of immune checkpoint inhibitor (ICI) benefit in non-small cell lung cancer (NSCLC) [JCR상위 1.7] Pre-treatment CT radiomics for predicting immunotherapy response in non-small cell lung cancer(NSCLC): RECIST vs. irRECIST criteria [JCR상위 1.7] Harmonization radiomics model to predict immune checkpoint inhibitor-related pneumonitis (CIP) in patients with non-small cell lung cancer (NSCLC) [JCR상위 1.7] AI-based radiomics model for predicting immune checkpoint inhibitor-related pneumonitis (CIP) in patients with advanced NSCLC: An external validation study |
SCIE | 1.7 | ONCOLOGY | ||||
|
Hong, Sukjin (Hong, S) |
Daegu Catholic Univ, Med Ctr, Daegu, South Korea |
|
|
[JCR상위 1.7] Factors influencing HBsAg clearance in children with chronic hepatitis B undergoing antiviral therapy: significance of age at treatment onset and HBeAg titer dynamics | SCIE | 1.7 | GASTROENTEROLOGY & HEPATOLOGY | bhchoi@knu.ac.kr; | ||
|
Hsu, Yao-Chun (Holden) (Hsu, YC) |
Fu Jen Catholic Univ, Kaohsiung, Taiwan |
|
|
[JCR상위 1.7] Multinational randomized trial to investigate the efficacy of tenofovir alafenamide in reducing adverse clinical events in chronic hepatitis B patients who are beyond treatment indications by current guidelines (ATTENTION trial): first interim analysis | SCIE | 1.7 | GASTROENTEROLOGY & HEPATOLOGY | limys@amc.seoul.kr; | ||
|
Hwang, Jun-Eul (Hwang, JE) |
Chonnam Natl Univ, Chonnam Natl Univ Hwasun Hosp, Dept Internal Med, Med Sch, Jeonnam, South Korea |
|
|
[JCR상위 1.7] Neoadjuvant Docetaxel, Oxaliplatin, and S-1 Plus Surgery and Adjuvant S-1 for Resectable Advanced Gastric Cancer: Updated Overall Survival Outcomes From Phase III PRODIGY | SCIE | 1.7 | ONCOLOGY | ykkang@amc.seoul.kr; | ||
|
Hwang, Sangyoun (Hwang, S) |
제1저자 |
Dongnam Inst Radiol & Med Sci, Dept Internal Med, Busan, South Korea Dongnam Inst Radiol & Med Sci, Busan, South Korea |
|
|
[JCR상위 1.7] Beneficial effect of combined radiation therapy in atezolizumab plus bevacizumab treatment of hepatocellular carcinoma patients with main portal vein tumor thrombosis [JCR상위 4.4] BENEFICIAL EFFECT OF COMBINED RADIATION THERAPY IN ATEZOLIZUMAB PLUS BEVACIZUMAB TREATMENT OF HEPATOCELLULAR CARCINOMA PATIENTS WITH MAIN PORTAL VEIN TUMOR THROMBOSIS OR BILE DUCT INVASION |
SCIE | 1.7 | GASTROENTEROLOGY & HEPATOLOGY | jheo@pusan.ac.kr; | |
|
Jang, Eun Sun (Jang, ES) |
Seoul Natl Univ, Bundang Hosp, Seongnam, South Korea Seoul Natl Univ, Bundang Hosp, Coll Med, Seongnam, South Korea |
|
|
[JCR상위 1.7] Multinational randomized trial to investigate the efficacy of tenofovir alafenamide in reducing adverse clinical events in chronic hepatitis B patients who are beyond treatment indications by current guidelines (ATTENTION trial): first interim analysis [JCR상위 3.2] Effect of direct-acting antivirals on disease burden of hepatitis C virus infection in South Korea in 2007-2021: a nationwide, multicentre, retrospective cohort study |
SCIE | 1.7 |
GASTROENTEROLOGY & HEPATOLOGY MEDICINE, GENERAL & INTERNAL |
limys@amc.seoul.kr; drwon1@snu.ac.kr;hanseungbong@gmail.com;ksukorea@yuhs.ac; |
||
|
Jang, Jessica (Jang, J) |
|
|
[JCR상위 1.7] Pre-treatment CT radiomics for predicting immunotherapy response in non-small cell lung cancer(NSCLC): RECIST vs. irRECIST criteria [JCR상위 1.7] Harmonization radiomics model to predict immune checkpoint inhibitor-related pneumonitis (CIP) in patients with non-small cell lung cancer (NSCLC) |
SCIE | 1.7 | ONCOLOGY | ||||
|
Jang, You Jin (Jang, YJ) |
Korea Univ Guro Hosp, Dept Surg, Seoul, South Korea |
|
|
[JCR상위 1.7] Neoadjuvant Docetaxel, Oxaliplatin, and S-1 Plus Surgery and Adjuvant S-1 for Resectable Advanced Gastric Cancer: Updated Overall Survival Outcomes From Phase III PRODIGY | SCIE | 1.7 | ONCOLOGY | ykkang@amc.seoul.kr; | ||
|
Jeon, Seob (Jeon, S) |
Soonchunhyang Univ, Cheonan Hosp, Coll Med, Dept Obstet & Gynecol, Cheonan, South Korea |
|
|
[JCR상위 1.7] Rationale and study design of the KOV-HIPEC-04: A phase III randomized controlled trial in primary stage III and IV ovarian cancer after interval cytoreductive surgery (FOCUS) [JCR상위 9.6] Therapeutic effects of surgical debulking of metastatic lymph nodes in cervical cancer IIICr: a trial protocol for a phase III, multicenter, randomized controlled study (KGOG1047/DEBULK trial) |
SCIE | 1.7 |
ONCOLOGY OBSTETRICS & GYNECOLOGY;ONCOLOGY |
rohjuwon@hanmail.net; | ||
|
Jeong, Oh (Jeong, O) |
Chonnam Natl Univ, Dept Surg, Med Sch, Hwasun, South Korea |
|
|
[JCR상위 1.7] Neoadjuvant Docetaxel, Oxaliplatin, and S-1 Plus Surgery and Adjuvant S-1 for Resectable Advanced Gastric Cancer: Updated Overall Survival Outcomes From Phase III PRODIGY | SCIE | 1.7 | ONCOLOGY | ykkang@amc.seoul.kr; | ||
|
Jeong, Seolhwa (Jeong, S) |
|
|
[JCR상위 1.7] Uncovering of NRAGE/JNK and PI3K/AKT pathways through serial WGS of patients with breast cancer | SCIE | 1.7 | ONCOLOGY | ||||
|
Jeong, Woon Kyung (Jeong, WK) |
|
|
[JCR상위 1.7] Early versus conventional adjuvant chemotherapy in stage III colon cancer: A multicenter, randomized, open-label, phase 3 trial | SCIE | 1.7 | ONCOLOGY |
페이지 이동: